Clin Liver Dis. 2001 Nov;5(4):1045-61.

Treatment of hepatitis C virus and HIV co-infections.

Source

Section of Hepatology, RUSH-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA.

Abstract

Hepatitis C coinfection is common in patients with HIV, particularly in injection-drug users. Hepatitis C virus levels tend to be higher in coinfected patients, and histologic progression is more rapid than in patients with HCV alone. The efficacy of interferon monotherapy in HIV patients with an adequate CD4 cell count is comparable to that observed in patients without HIV. The combination of interferon plus ribavirin and pegylated interferon will further improve response rates. Interferon therapy is associated with leukopenia and a decrease in absolute CD4 cell count. Some concern remains that ribavirin might reduce the activity of pyrimidine analogues such as zidovudine and stavudine, and HIV-RNA levels should be followed when these medications are given concurrently. It is hoped that in time, new drug development will make the multiple-drug therapeutic strategy that has been highly successful in the management of HIV feasible for the treatment of HCV.

PMID:: 11685794; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

MD Consult

Medical

Molecular Biology Databases

RIBAVIRIN - HSDB

Supplemental Content

Related citations

[Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up]. [Rev Med Interne. 2005]
[Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
Seydi M, Morlat P, Bonnet F, Rambeloarisoa J, Bernard N, Lacoste D, Bonarek M, Trimoulet P, Ramanampamonjy R, Lafon ME, et al. Rev Med Interne. 2005 Apr; 26(4):280-7.
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients. [J Antimicrob Chemother. 2007]
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
Pineda JA, Mira JA, Gil Ide L, Valera-Bestard B, Rivero A, Merino D, Girón-González JA, Ríos-Villegas MJ, González-Serrano M, Collado A, et al. J Antimicrob Chemother. 2007 Dec; 60(6):1347-54. Epub 2007 Oct 14.
Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort. [Infection. 2008]
Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort.
Righi E, Beltrame A, Bassetti M, Lindstrom V, Mazzarello G, Dentone C, Di Biagio A, Ratto S, Viscoli C. Infection. 2008 Aug; 36(4):358-61. Epub 2008 Jul 19.
Review Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin. [Semin Liver Dis. 2005]
Review Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N. Semin Liver Dis. 2005 Feb; 25(1):33-51.
Review Therapy of hepatitis C in HIV-coinfection. [Eur J Med Res. 2004]
Review Therapy of hepatitis C in HIV-coinfection.
Rockstroh JK, Vogel M. Eur J Med Res. 2004 Jun 30; 9(6):304-8.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of hepatitis C virus and HIV co-infections.
Treatment of hepatitis C virus and HIV co-infections.
Clin Liver Dis. 2001 Nov ;5(4):1045-61.

PubMed
Inflammatory masses associated with intrathecal drug infusion: a review of precl...
Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data.
Pain Med. 2002 Dec ;3(4):300-12.

PubMed
Drug use and other risk factors related to lower body mass index among HIV-infec...
Drug use and other risk factors related to lower body mass index among HIV-infected individuals.
Drug Alcohol Depend. 2008 May 1 ;95(1-2):30-6. Epub 2008 Feb 19 .

PubMed
Nested effects models for high-dimensional phenotyping screens.
Nested effects models for high-dimensional phenotyping screens.
Bioinformatics. 2007 Jul 1 ;23(13):i305-12.

PubMed
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the...
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks.
Radiat Res. 2007 Apr ;167(4):396-416.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: